Literature DB >> 11220103

[Transarterial chemoembolization (TACE) of liver metastases. A palliative therapeutic approach].

S Zangos1, M G Mack, R Straub, K Engelmann, K Eichler, J Balzer, T J Vogl.   

Abstract

Metastatic involvement of the liver determines the treatment. Hepatic artery chemoembolization (TACE) represents a safe palliative treatment for patients with unresectable liver metastases. Technical treatment, indication and results of the TACE are reported. The results of TACE depend on primary cancer, size and vascularisation of the hepatic tumors. Our results with out patient treatment of 245 patients prove that TACE results in a extremely low rate of side effects. Combination of TACE with local ablative treatment may present potentially curative treatment option for unresectable tumors.

Entities:  

Mesh:

Year:  2001        PMID: 11220103     DOI: 10.1007/s001170050931

Source DB:  PubMed          Journal:  Radiologe        ISSN: 0033-832X            Impact factor:   0.635


  3 in total

1.  [Experimental study in the effects of combined transarterial chemoembolization and laser thermotherapy in hepatocellular carcinoma].

Authors:  Jun Qian; Lan Ni; Adel Maataoui; Elsie Oppermann; Thomas Joesf Vogt
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2005

Review 2.  Interventional therapies of unresectable liver metastases.

Authors:  Jun Qian
Journal:  J Cancer Res Clin Oncol       Date:  2011-09-11       Impact factor: 4.553

3.  Role and limitation of FMPSPGR dynamic contrast scanning in the follow-up of patients with hepatocellular carcinoma treated by TACE.

Authors:  Fu-Hua Yan; Kang-Rong Zhou; Jie-Min Cheng; Jian-Hua Wang; Zhi-Ping Yan; Reng-Rong Da; Jia Fan; Yuan Ji
Journal:  World J Gastroenterol       Date:  2002-08       Impact factor: 5.742

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.